Sofosbuvir, a Significant Paradigm Change in HCV Treatment

Journal of Clinical and Translational Hepatology
doi 10.14218/jcth.2014.00041
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Xia & He Publishing

Related search

HCV/HIV Coinfection: A New Treatment Paradigm

Gastroenterology
HepatologyGastroenterology
2015English

Sofosbuvir and Velpatasvir: A Complete Pan-Genotypic Treatment for HCV Patients

Turkish Journal of Gastroenterology
Gastroenterology
2016English

Secondary Occult Hepatitis C Virus Infection (HCV) in Chronic HCV Patients After Treatment With Sofosbuvir and Daclatasvir

International Journal of Current Microbiology and Applied Sciences
2018English

Cost Effectiveness Analysis of Sofosbuvir and Ledipasvir/Sofosbuvir in Hepatitis C Virus (HCV) Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Sofosbuvir, Peg Interferon & Ribavirin for Retreatment of HCV Genotype 1b Following Sofosbuvir and Ledipasvir Failure

Hepatology
MedicineHepatology
2018English

A Prospective Study of Daclatasvir and Sofosbuvir in Chronic HCV-infected Kidney Transplant Recipients

BMC Nephrology
Nephrology
2019English

Ledipasvir and Sofosbuvir for HCV-infection in Patients Coinfected With HBV

Antiviral Therapy
Infectious DiseasesPharmacology
2016English

Change of Transfusion and Treatment Paradigm in Major Trauma Patients

Anaesthesia
AnesthesiologyPain Medicine
2017English

Elbasvir/Grazoprevir and Sofosbuvir for HCV Genotype 3 Infection With Compensated Cirrhosis: A Randomized Trial

Hepatology
MedicineHepatology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy